Kevin Buckley

Shareholder Kevin Buckley

kevin@torreypineslaw.com
+1 (858) 800-2537 x702
vCard

Kevin Buckley is a Shareholder with Torrey Pines Law Group and is an experienced intellectual property, transactional, and regulatory attorney for high technology businesses. His clients include biotechnology, pharmaceutical, specialty chemical, medical device, digital health, diagnostics, software, analytics, mobile app, and convergence technology businesses. The "convergence" often includes machine learning, artificial intelligence, and complex algorithms. He has served in leadership positions with large law firms and has managed longstanding relationships with clients including multi-national corporations, private research institutes, and the nation's premier public university system.

His law practice focuses on:

  • IP, transactional, and regulatory counseling
  • International patent preparation and prosecution
  • Corporate and commercial transactions
  • Technology transfer and technology licensing
  • Investment funding and investment due diligence
  • Legal opinion drafting
  • Litigation avoidance, and
  • IP infringement litigation

Prior to founding Torrey Pines Law Group, he led the Life Sciences Practice of a large law firm. He has also been chief legal counsel for the research department of a large American university. In addition, he was chief legal counsel to a private research foundation where he advised its Board with complex corporate governance matters. For many years, Kevin was recognized nationally for his law practice by The Best Lawyers in America.

Kevin has also been an academic advisor to entrepreneurship centers at the University of Pennsylvania and Washington University in St. Louis. Kevin taught a Biotechnology Law intersession course at Washington University School of Law where he was an adjunct professor.

Kevin's interests outside his law practice include mountaineering and hiking the California backcountry. What he is most passionate about, however, is spending time outdoors every day with his daughter Sophie, his family, and friends.

Before becoming a patent attorney, Kevin was a biochemist in both academics and industry. Kevin received a Bachelor of Science degree in Biochemistry/Chemistry from UC San Diego where he was an undergraduate Research Scholar. He then received a Juris Doctorate from the University of Pittsburgh School of Law where he was Editor-in-Chief of the Pittsburgh Journal of Technology Law and Policy.

Distinctions

Kevin has been selected by his peers for inclusion in:

  • The Best Lawyers in America
  • Philadelphia's Best Lawyers
  • SuperLawyers Rising Star
  • St. Louis Magazine Best Lawyers
  • St. Louis Business Journal "Who's Who in Technology"
  • St. Louis Business Journal "40 Under Forty"

Selected Speaking Engagements

  • Presenter, Legal, Financial and Tax Strategies for Start-Ups, Sanford Consortium for Regenerative Medicine, San Diego, CA (January 28, 2015)
  • PresenterIP Strategy Informed by the Commercialization Process, Pennsylvania Bio Inaugural Knowledge Fair, Valley Forge, PA (June 8, 2011)
  • Guest LecturerEntrepreneurial Investing - Management 424/524, Washington University Olin Business School, St. Louis, MO (October 13, 2009 and March 2, 2010)
  • Adjunct Professor Biotechnology Law From Patents to Food-Drug-Planting Approvals (Intersession Course) - Washington University School of Law, St. Louis, MO (January 11-15, 2010)
  • Co-Presenter (Fully-Accredited Continuing Legal Education), In re '318 Patent Infringement Litigation - Better to be Smart than Lucky: The Problems of Obtaining a Patent for Guessing Right, Monsanto Company (December 7, 2009)
  • PanelistBringing Overseas Start-Ups Into the U.S. Inaugural Global Healthcare Investing Conference, Cleveland, OH (June 20, 2007)

Jurisdictions

Kevin is registered to practice before the U.S. Patent & Trademark Office, and admitted to practice law in Missouri and Pennsylvania. He is also admitted to the Federal Circuit Court of Appeals.